Abstract:The development of ZFN, TALEN, and CRISPR/Cas9 systems has simplified the process of generating knockout (KO) and knock-in (KI) rats in addition to mice. However, in rats, an efficient genome editing technique that uses in vitro fertilized oocytes has not been established. Recently, we reported the stable generation of offspring from five standard strains of rats by superovulation and in vitro fertilization (IVF). Furthermore, genome-edited rats can be easily generated by electroporation. First, juvenile female rats are administered LHRH (luteinizing hormone-releasing hormone) to synchronize the estrous cycle and then AIS (Automatic Identification System) with PMSG (pregnant mare serum gonadotropin) before hCG (human chorionic gonadotropin) for superovulation. Sperm collected from a sexually mature male rat the following morning is then pre-cultured. Cumulus cell-oocyte complexes (COCs) are collected from female rats under anesthesia, and COCs are induced into a medium containing concentration-adjusted sperm. Thereafter, oocytes with two pronucleus are selected as fertilized oocytes. Next, fertilized oocytes are transferred into a glass chamber containing CRISPR ribonucleoprotein (RNP) complexes formed from gRNA and Cas9 protein. After electroporation, fertilized oocytes are then immediately transferred to culture medium. The next day, embryos are transferred into the oviduct of pseudopregnant female rats. Using the above method, offspring can be obtained 22 days after the day of embryo transfer. In this paper, we outline a method allowing simple and efficient generation of genetically modified rats without the need for technically difficult micromanipulation techniques.

Application of genome editing technologies in rats for human disease models

Retake the center stage--new development of rat genetics.

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Progress and Prospects in Rat Genetics: a Community View.

Generation of site-specific mutations in the rat genome via CRISPR/Cas9.

Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform

Gene edited animal models applied in human disease research

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics

Genetically modified mice as a tool for the study of human diseases

Use of rodents as models of human diseases

Genome-edited Rabbits: Unleashing the Potential of a Promising Experimental Animal Model Across Diverse Diseases

Genome editing methods in animal models

CRISPR/Cas-mediated Genome Editing in the Rat Via Direct Injection of One-Cell Embryos.

Application of CRISPR/Cas9 System in Establishing Large Animal Models

Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes

Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters

Applications of Genome Editing Technology in Animal Disease Modeling and Gene Therapy

Advanced genetic and viral methods for labelling and manipulation of oxytocin and vasopressin neurones in rats

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes

Next Generation Transgenic Rat Model Production

A Simple and Efficient Method for Generating KO Rats Using In Vitro Fertilized Oocytes